Protagonist Therapeutics Inc logo

Protagonist Therapeutics Inc

$ 8.32 0 (0%) 12:52 PM EST
P/E:
At Loss
P/B:
1.51
Market Cap:
$ 406.66M
Enterprise V:
$ 121.29M
Volume:
239.74K
Avg Vol (2M):
923.00K
Also Trade In:
Volume:
239.74K
Market Cap $:
406.66M
PE Ratio:
At Loss
Avg Vol (2-Month):
923.00K
Enterprise Value $:
121.29M
PB Ratio:
1.51
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. The Company operates and manages its business as one operating segment.
Name Current Vs Industry Vs History
Cash-To-Debt 60.84
Equity-to-Asset 0.86
Debt-to-Equity 0.02
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.39
Distress
Grey
Safe
Beneish M-Score -3.46
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 43.04
9-Day RSI 41.37
14-Day RSI 41.96
6-1 Month Momentum % -63.96
12-1 Month Momentum % -47.72

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.59
Quick Ratio 7.59
Cash Ratio 7.28

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -27.3

Financials (Next Earnings Date:2022-11-03 Est.)

PTGX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PTGX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 45.484
EPS (TTM) ($) -2.74
Beta 2.75
Volatility % 126.3
14-Day RSI 41.96
14-Day ATR ($) 0.566327
20-Day SMA ($) 8.6485
12-1 Month Momentum % -47.72
52-Week Range ($) 6.91 - 38.11
Shares Outstanding (Mil) 49.08

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Protagonist Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Protagonist Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.